IDiyas

For the Inventor, By the Inventor

Horsham, United Kingdom

David Andrew Sandham

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 5.4

ph-index = 4

Forward Citations = 46(Granted Patents)


Location History:

  • Horsham, West Sussex, GB (2008)
  • Horsham, GB (2005 - 2023)

Company Filing History:

goldMedal16 out of 3,923 
 
Novartis Ag
 patents
silverMedal1 out of 2 
 
Novarits Ag
 patents
bronzeMedal2 out of 832,680 
Other
 patents

Years Active: 2005-2023

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):
1. 11672782 - Carboxamide derivatives (2023-06-13),
2. 10195181 - Carboxamide derivatives (2019-02-05),
3. 10183025 - Autotaxin inhibitors (2019-01-22),
4. 9763957 - Autotaxin inhibitors (2017-09-19),
5. 9403810 - Carboxamide derivatives (2016-08-02),
6. 9334271 - Purine derivatives and their use in the treatment of disease (2016-05-10),
7. 9169251 - Pyrrolopyridine derivatives and their use as CRTH2 antagonists (2015-10-27),
8. 8791256 - Pyrrolopyridine derivatives and their use as CRTH2 antagonists (2014-07-29),
9. 8470848 - Organic compounds (2013-06-25),
10. 8455645 - Pyrrolopyridine derivatives and their use as CRTH2 antagonists (2013-06-04),
11. 8431703 - Pyrrolopyridine compounds and their use in treating disease (2013-04-30),
12. 7888383 - Organic compounds (2011-02-15),
13. 7745462 - Quinoline-2-one derivatives for the treatment of airways diseases (2010-06-29),
14. 7678826 - Organic compounds for the treatment of inflammatory or allergic conditions (2010-03-16),
15. 7666878 - Pyrrolopyridine derivatives and their use as Crth2 antagonists (2010-02-23),

Title: David Andrew Sandham: Innovator in Pharmaceutical Chemistry

Introduction

David Andrew Sandham is a prominent inventor based in Horsham, GB, with a remarkable portfolio that includes 19 patents. His work primarily focuses on pharmaceutical chemistry, where he has made significant contributions to the development of innovative compounds that hold therapeutic potential.

Latest Patents

Among his most recent patents are advancements in carboxamide derivatives. These patents provide a compound of formula (I) or a pharmaceutically acceptable salt thereof, along with a method for manufacturing these compounds. The inventions also detail their therapeutic uses and offer a combination of pharmacologically active agents within a pharmaceutical composition. This groundbreaking work exemplifies his dedication to enhancing medical treatments through innovative chemical solutions.

Career Highlights

Throughout his career, David has contributed to leading pharmaceutical companies, notably Novartis AG. His experience in such esteemed organizations underscores his expertise in the field and the impact of his inventions on the pharmaceutical industry. His innovative mindset continues to drive advancements in drug development.

Collaborations

David has collaborated with notable professionals, including Kamlesh Jagdis Bala and Simon James Watson. These partnerships reflect his ability to work synergistically with other experts, enhancing the potential for groundbreaking innovations in pharmaceutical research.

Conclusion

David Andrew Sandham's contributions to the field of pharmaceutical chemistry through his extensive patent portfolio are commendable. His innovative developments in carboxamide derivatives pave the way for new therapeutic avenues, showcasing his importance as an inventor in the industry. As his career progresses, his impact on pharmaceutical advancements is undoubtedly set to grow.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…